Menu
  • Find a Doctor
  • International Patients
  • Newsroom
  • Contact Us
  • Patients & Families
  • Education
  • Research
  • Departments & People
  • Transfer a Patient
  • Donate to The Barrow

    Contact Dr. George

    [email protected]

    Andrew George, PhD

    Assistant Professor, Neurobiology (602) 406-3398

    Andrew George, PhD, is a assistant professor in the Department of Neurobiology at Barrow Neurological Institute. He is a member of the International Society for Neuroethology, The J.B. Johnston Club, and the Society for Neuroscience.

    Dr. George received his doctorate from The University of Texas and completed his fellowship from Washington University, both in Neuroscience.

    Dr. George’s research interests includes the role of nicotinic acetylcholine receptors (nAChRs) in addiction and neurodegenerative disease, sensory processing and temporal coding in vertebrate neural systems, cellular and molecular mechanisms that mediate neural intrinsic excitability, mechanisms of sensorimotor adaptation in vertebrates and the relationship between calcium signaling, neural activity and linear memory integration.

    Education & Training
    • Postdoctoral Fellowship, Washington University, Neuroscience, 2010
    • PhD, The University of Texas, Neuroscience, 2009
    • BS, Arizona State University, 1999
    Professional Memberships
    • The J.B. Johnston Club
    • Society for Neuroscience
    • International Society for Neuroethology
    Honors and Awards
    • Young Investigator Award, Wellcome Trust, Platform Presentation, 2014
    • Graduate Research Seminar Travel Award, Gordon Research Conference, 2008
    • Heiligenberg Travel Award, Gordon Research Conference on Neuroethology, 2008
    • Frank R. Lillie Fellowship, Marine Biological Laboratories in Woods Hole, Massachusetts, 2007
    • Outstanding Teaching Award, School of Biological Sciences, University of Texas at Austin, 2007
    • Travel Award, Center for Perceptual Systems, University of Texas at Austin, 2005
    • Professional Development Award, The University of Texas at Austin, 2005-2006
    • David Bruton, Jr. Fellowship, The University of Texas at Austin, Institute for Neuroscience, 2004-2005
    • Honorary Graduate Fellowship, Institute for Neuroscience, The University of Texas at Austin, 2003-2004
    • Summer Research Fellowship, NIH Bridges to Biomedical Careers, Arizona State University, 1998
    Selected Publications
    1. Moretti M, Zoli M, George AA, Lukas RJ, Pistillo F, Maskos U, Whiteaker P, Gotti C. The novel alpha7beta2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization. Mol Pharmacol. Sep 2014;86(3):306-317.
    2. Murray TA, Bertrand D, Papke RL, George AA, Pantoja R, Srinivasan R, Liu Q, Wu J, Whiteaker P, Lester HA, Lukas RJ. alpha7beta2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their alpha7-alpha7 interfaces. Mol Pharmacol. Feb 2012;81(2):175-188.
    3. George AA, Lucero LM, Damaj MI, Lukas RJ, Chen X, Whiteaker P. Function of human alpha3beta4alpha5 nicotinic acetylcholine receptors is reduced by the alpha5(D398N) variant. J Biol Chem. Jul 20 2012;287(30):25151-25162.
    4. George AA, Macleod GT, Zakon HH. Calcium-dependent phosphorylation regulates neuronal stability and plasticity in a highly precise pacemaker nucleus. J Neurophysiol. Jul 2011;106(1):319-331.
    5. George AA, Lyons-Warren AM, Ma X, Carlson BA. A diversity of synaptic filters are created by temporal summation of excitation and inhibition. J Neurosci. Oct 12 2011;31(41):14721-14734.
    6. Oestreich J, Dembrow NC, George AA, Zakon HH. A “sample-and-hold” pulse-counting integrator as a mechanism for graded memory underlying sensorimotor adaptation. Neuron. Feb 16 2006;49(4):577-588.
    7. Peng JH, Fryer JD, Hurst RS, Schroeder KM, George AA, Morrissy S, Groppi VE, Leonard SS, Lukas RJ. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells. J Pharmacol Exp Ther. Apr 2005;313(1):24-35.
    8. Wu J, Kuo YP, George AA, Xu L, Hu J, Lukas RJ. beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem. Sep 3 2004;279(36):37842-37851.
    9. Wu J, George AA, Schroeder KM, Xu L, Marxer-Miller S, Lucero L, Lukas RJ. Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J Pharmacol Exp Ther. Oct 2004;311(1):80-91.
    10. Eaton JB, Peng JH, Schroeder KM, George AA, Fryer JD, Krishnan C, Buhlman L, Kuo YP, Steinlein O, Lukas RJ. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells. Mol Pharmacol. Dec 2003;64(6):1283-1294.

    About Barrow Neurological Institute

    Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.